Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P990080/S067

TECNIS Foldable Acrylic IOL with OptiEdge, Model ZA9003

Johnson & Johnson Surgical Vision, Inc. · Decision date Oct 19, 2026

MEDTECHLEDGER EXPLANATIONP990080/S067

What did the FDA decide?

FDA database record P990080/S067 describes a 30-day notice for the TECNIS Foldable Acrylic IOL with OptiEdge, Model ZA9003. The stated change is the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site. The applicant is Johnson & Johnson Surgical Vision, Inc., and the supplement type is a process change involving manufacturer, sterilizer, packager, or supplier.

This supplement does not represent a new approval of the intraocular lens system. The record identifies the original PMA number P990080, but the notice concerns only the reported testing location change. The source statement describes the purpose of the change; it does not provide independent proof of safety or clinical effectiveness. Specific details about validation results, test methods, or manufacturing impact are absent from the supplied fields.

FDA approval order statement

the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 19, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P990080/S067
Regulatory pathway
PMA supplement
Product code
HQL
Decision code
OK30
Decision date
Oct 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

For the original device and its historical approval scope, see PMA P990080. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P990080 · Original PMA

    CEEON EDGE FOLDABLE ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS, MODEL 911A

  2. P990080/S067 received

    Application receipt date recorded by FDA.

  3. P990080/S067 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P990080. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990080

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records